Global Neurology & Neuroscience Market Outlook
The worldwide market for neurological therapeutics is forecast to surge from ≈ US $67 billion in 2024 to nearly US $95 billion by 2029 (CAGR ≈ 7.1%). Meanwhile, the neuroscience tools & technologies sector is set to reach ≈ US $65 billion by 2030, underpinned by rapid investment in brain–computer interfaces, advanced neuroimaging, and precision neurogenetics. This growth trajectory positions our event among the most relevant neurology conferences and neuroscience conferences on the 2025 calendar.
Key Growth Drivers
-
Ageing demographics: Alzheimer’s cases may more than double by 2050, ramping up demand for disease‑modifying drugs—priority topic at global Neurology 2026 conference.
-
Tech convergence: AI‑guided drug discovery, quantum MRI, and portable neuro‑devices headline upcoming Neurology Conferences 2026.
-
Policy & funding tailwinds: The NIH BRAIN Initiative (≈ US $320 M, 2025) and new Horizon Europe calls speed translational breakthroughs, showcased at leading Stroke Conferences.
Breakthrough Highlights (2024–2025)
First fully‑implanted BCI enables real‑time phone control—demo slated for top Neuro Conference 2026.
Allele‑selective CRISPR moves Huntington’s therapy toward clinics—spotlight in major Brain Stimulation Conference sessions.
Ultra‑high‑field 14 T MRI delivers sub‑millimetre brain maps—featured study at 2025 Upcoming Neurology Conferences.
Funding Snapshot (2025)
| Programme | 2025 Budget | Focus Areas |
|---|---|---|
| NIH BRAIN Initiative (US) | ≈ US $320 M | Neurotech tools, brain mapping |
| Horizon Europe Cluster 1 | ≈ €1.2 B* | AI for mental health, advanced neuro-therapies |
| Private VC & Corporate | US $3 B+ ('24-'25) | BCIs, neurostimulation, digital biomarkers |
*Total Cluster 1 health call budgets, multiple brain-focused topics.
